Continued efforts to translate diabetes cardiovascular outcome trials into clinical practice

Diabetic patients suffer from a high rate of cardiovascular events and such risk increases with HbA1c. However, lowering HbA1c does not appear to yield the same benefit on macrovascular endpoints, as observed for microvascular endpoints. As the number of glucose-lowering medications increases, clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Avogaro, Angelo, Fadini, Gian Paolo, Sesti, Giorgio, Bonora, Enzo, Del Prato, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982334/
https://www.ncbi.nlm.nih.gov/pubmed/27514514
http://dx.doi.org/10.1186/s12933-016-0431-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982334/
https://www.ncbi.nlm.nih.gov/pubmed/27514514
http://dx.doi.org/10.1186/s12933-016-0431-4

Ejemplares similares